Gilead Sciences Inc (NASDAQ: GILD)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/17/2020
Closing price: 62.98
|Support price level:||N/A|
|Resistance price level:||$64.12|
|Relative strength index (14-day RSI)||25.9|
- GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- With a -8.3 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- GILD is one of this month's worst performers with a return of -4.1%, underperforming 90 percent of stocks in the S&P-100.
- Down 3.2 percent, GILD is one of this week's biggest decliners.
- Volatility is forecast to fall over the next month.
- With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 6.4% in the next week.
- 15.1% in the next month.
- 45.5% in the next year.